Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression
Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.